Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of the SurgiStim3 Electrical Stimulation Device in Persons Undergoing Anterior Cruciate Ligament Repair

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Agree to provide informed consent to be included within this ACL study~* Demonstrate a continued willingness to be compliant with the parameters established under the study;~* Have no history of drug or alcohol abuse in the last 2 years;~* Be either a male or female adult between the ages of 18 and 64;~* Be undergoing a surgical repair of the anterior cruciate ligament (ACL) using either a hamstring, patella tendon, Achilles tendon, or allograft procedure; and~* Understand that there is no financial remuneration for participation in the study.~Exclusion Criteria:~* Pregnant women~* Insulin dependent diabetic patients~* Patients with a demand type pacemaker~* Patients who have a malignant tumor (other than basal cell epithelioma)~* Patients with a known history of alcohol or drug abuse in the last 2 years~* Patients who will not agree to provide informed consent to be included within this ACL study~* Patients who demonstrate a continued unwillingness to be compliant with the parameters established under this study.~* Poor healers as identified by the patient's medical history~* Patients who have a history of sensitivity to surgical tape, electrode adhesives, etc.~* Patients with a known history of RSD (reflex sympathetic dystrophy)~* Patients with a history of chronic pain (on opiates or high dosage of NSAIDS for 3 months or greater)~* Patients who have previously undergone an ACL reconstruction on the same knee~* Patients with clinically varicose veins (clinically significant or symptomatic)~* Patients whose history shows an abuse of diuretics or anti-inflammatory medications~* Patients who will undergo multiple ligament surgery (i.e., ACL plus PCL, MCL, and/or LCL)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: PLACEBO_COMPARATOR): None
- 2 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).